Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,460 | 372 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $812.23 | 64 | $0 (2024) |
| Lilly USA, LLC | $656.01 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $632.16 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $412.58 | 37 | $0 (2022) |
| Novo Nordisk Inc | $376.21 | 38 | $0 (2024) |
| Amgen Inc. | $374.20 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $288.55 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $234.14 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $172.82 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $163.40 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $984.17 | 58 | ABBVIE INC. ($209.72) |
| 2023 | $1,046 | 55 | AbbVie Inc. ($259.79) |
| 2022 | $643.70 | 35 | ABBVIE INC. ($165.95) |
| 2021 | $651.45 | 48 | AbbVie Inc. ($176.77) |
| 2020 | $353.86 | 23 | Lilly USA, LLC ($132.27) |
| 2019 | $444.10 | 26 | Janssen Pharmaceuticals, Inc ($99.59) |
| 2018 | $445.51 | 35 | Janssen Pharmaceuticals, Inc ($77.12) |
| 2017 | $896.85 | 93 | Novo Nordisk Inc ($165.62) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes Care | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 11/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: Hyperkalemia | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Cardio-renal | ||||||
| 09/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Obesity | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 268 | 569 | $62,908 | $35,390 |
| 2022 | 5 | 288 | 547 | $61,733 | $35,520 |
| 2021 | 4 | 293 | 566 | $61,850 | $35,629 |
| 2020 | 6 | 351 | 638 | $73,235 | $33,203 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 174 | 451 | $45,551 | $27,324 | 60.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 66 | 86 | $8,084 | $3,664 | 45.3% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2023 | 14 | 18 | $6,480 | $2,665 | 41.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 14 | 14 | $2,793 | $1,736 | 62.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 182 | 427 | $43,127 | $26,274 | 60.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 62 | 73 | $6,862 | $3,263 | 47.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 18 | 21 | $3,570 | $2,323 | 65.1% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2022 | 14 | 14 | $4,610 | $2,133 | 46.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 12 | 12 | $3,564 | $1,527 | 42.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 187 | 436 | $45,776 | $26,887 | 58.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 64 | 83 | $6,698 | $3,523 | 52.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 31 | 35 | $5,572 | $3,349 | 60.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Facility | 2021 | 11 | 12 | $3,804 | $1,870 | 49.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 191 | 428 | $46,224 | $21,455 | 46.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 88 | 127 | $8,890 | $4,665 | 52.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 28 | 36 | $5,472 | $2,565 | 46.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Facility | 2020 | 18 | 20 | $6,340 | $2,530 | 39.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2020 | 12 | 12 | $3,954 | $1,363 | 34.5% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 14 | 15 | $2,355 | $624.81 | 26.5% |
About Dr. Melissa Becker, MD
Dr. Melissa Becker, MD is a Family Medicine healthcare provider based in Ontario, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174514087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Becker, MD has received a total of $5,465 in payments from pharmaceutical and medical device companies, with $984.17 received in 2024. These payments were reported across 373 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,460).
As a Medicare-enrolled provider, Becker has provided services to 1,200 Medicare beneficiaries, totaling 2,320 services with total Medicare billing of $139,742. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Ontario, OH
- Active Since 10/31/2005
- Last Updated 12/28/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174514087
Products in Payments
- UBRELVY (Drug) $396.61
- FARXIGA (Drug) $394.79
- VRAYLAR (Drug) $324.65
- XARELTO (Drug) $252.09
- JARDIANCE (Drug) $249.19
- TRELEGY ELLIPTA (Drug) $202.97
- MOUNJARO (Drug) $184.67
- INVOKANA (Drug) $160.49
- BREZTRI (Drug) $146.04
- QULIPTA (Drug) $137.29
- TRULICITY (Drug) $133.09
- EMGALITY (Drug) $123.96
- Victoza (Drug) $103.68
- Otezla (Drug) $102.07
- Aimovig (Biological) $100.57
- NURTEC ODT (Drug) $97.62
- Vascepa (Drug) $95.21
- Trintellix (Drug) $91.99
- ELIQUIS (Drug) $89.03
- Prolia (Biological) $84.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Ontario
Renu Bhupathy, M.d, M.D
Family Medicine — Payments: $18,525
Harold Brown, Do, DO
Family Medicine — Payments: $15,100
Dr. Gordon Long, M.d, M.D
Family Medicine — Payments: $14,963
Edward Adkins, M.d, M.D
Family Medicine — Payments: $14,470
Dr. Charles Ho, M.d, M.D
Family Medicine — Payments: $2,949
Judith Cabrera, Md, MD
Family Medicine — Payments: $2,574